Investing Profile
Jim Tananbaum
VCInvestorCEOFounder
Founder and CEO at Foresite Capital.
foresitecapital.com/people/ji...San Francisco, California
Your Intro Paths to Jim Tananbaum
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Jim is a member of
Harvard Business School Network
421 CONNECTIONS
Massachusetts Institute of Technology Network
177 CONNECTIONS
Yale University Network
126 CONNECTIONS
Harvard Medical School Network
20 CONNECTIONS
Sierra Ventures Network
13 CONNECTIONS
Find Jim Tananbaum on
cbCurrent Investing Position
Foresite Capital Investor
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
33
Current Fund Size
$668M
Jim Tananbaum is on these Sector & Stage Rankings
Consumer Health (Seed)Digital Health (Seed)BioTech (Seed)Health & Hospital Services (Seed)Health IT (Seed)Consumer Health (Series A)Digital Health (Series A)BioTech (Series A)Health & Hospital Services (Series A)Health IT (Series A)Consumer Health (Series B)Digital Health (Series B)BioTech (Series B)Health & Hospital Services (Series B)Health IT (Series B)San Francisco Bay Area
Jim Tananbaum's Investments On Record (21)
Company | StageDateRound Size | Total Raised |
---|---|---|
Foresight Diagnostics | Series BJul 2024$33M Series BApr 2023$59M | $110M |
Element Biosciences | Series DJul 2024$280M Series CJun 2021$280M | $550M |
Alumis | Series CMar 2024$260M Series AMay 2021$70M | $330M |
Genomics | Series CJan 2024$45M Series UnknownMar 2021$30M | $84M |
evonetix | Series BFeb 2023$24M Series BMar 2020$30M | $66M |
DNAnexus | Series HMar 2022$200M Series GJun 2020$100M Series FFeb 2019$68M Series EJan 2018$58M | $460M |
ImmPACT Bio | Series BJan 2022$140M | $140M |
XinThera | Series BAug 2021$50M | $50M |
Jim Tananbaum's Experience
Co-Founder and Chief Executive Officer Theravance (THRX)Present
Co-Founder and Managing Director PVP2 & PVP3 Prospect Venture PartnersPresent
Founder and CEO Foresite Capital ManagementPresent
Partner Sierra Ventures1993 - 1997
Co-Founder and CEO GelTex (acquired by Genzyme for $1.6 B)1991 - 1992
Jim Tananbaum's Education
Harvard Business School mba
Harvard Medical School Doctor of Medicine (MD)
Massachusetts Institute of Technology Master of Science (M.S.) HST - information theory
Yale University BS BSEE, Math, computer science
Investors who invest with Jim Tananbaum